Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90,082 | 78,872 | 83,969 | 36,942 | 21,933 |
| Marketable Securities | N/A | 16,410 | 26,621 | 87,675 | 120,085 |
| Receivables | 2,488 | 1,531 | 1,214 | 1,431 | 880 |
| TOTAL | $94,341 | $99,583 | $112,486 | $129,229 | $144,025 |
| Non-Current Assets | |||||
| PPE Net | 9,150 | 9,402 | 9,667 | 10,145 | 10,421 |
| Investments And Advances | 10,969 | 14,377 | 17,675 | 22,224 | 24,665 |
| Intangibles | 0 | 66,307 | 66,307 | 66,307 | 66,307 |
| Other Non-Current Assets | 2,817 | 2,901 | 3,081 | 0 | 0 |
| TOTAL | $22,936 | $92,987 | $96,730 | $98,676 | $101,393 |
| Total Assets | $117,277 | $192,570 | $209,216 | $227,905 | $245,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,199 | 7,940 | 6,828 | 9,429 | 8,511 |
| Other current liabilities | 203 | 342 | 982 | 1,331 | 770 |
| TOTAL | $8,817 | $8,799 | $8,823 | $11,239 | $12,668 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 649 |
| Other Non-Current Liabilities | 24,823 | 6,644 | 6,523 | 3,126 | 4,161 |
| TOTAL | $24,823 | $19,305 | $19,184 | $16,432 | $17,478 |
| Total Liabilities | $33,640 | $28,104 | $28,007 | $27,671 | $30,146 |
| Shareholders' Equity | |||||
| Common Shares | 884,623 | 884,623 | 882,143 | 879,405 | 878,805 |
| Retained earnings | -942,559 | -857,264 | -831,187 | -805,221 | -784,325 |
| Other shareholders' equity | -48,217 | -48,244 | -48,192 | -48,170 | -48,197 |
| TOTAL | $83,637 | $164,466 | $181,209 | $200,234 | $215,272 |
| Total Liabilities And Equity | $117,277 | $192,570 | $209,216 | $227,905 | $245,418 |